Croatia vs Turkey: Cause of death, by non-communicable diseases, ages 5-14
Croatia
56.5%
in 2021
Turkey
56.0%
in 2021
Croatia rank
42nd
Turkey rank
43rd
Cause of death, by non-communicable diseases, ages 5-14 over time
- Croatia
- Turkey
How they compare
Croatia currently reports 56.5% against 56.0% in Turkey, a difference of 0.5%.
The two have swapped places 3 times across 6 shared years of data; in 2000 it was Turkey ahead.
Croatia ranks 42nd and Turkey ranks 43rd of 185 countries.
Across the 3 decades both report, Croatia averaged higher in 1 and Turkey in 2.
Head to head by decade
| Decade | Croatia | Turkey | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 41.9% | 47.1% | 5.2% | Turkey |
| 2010s | 55.5% | 56.5% | 1.0% | Turkey |
| 2020s | 63.5% | 56.2% | 7.3% | Croatia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 5-14, Croatia or Turkey?
- Croatia, at 56.5% against 56.0% in Turkey as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 5-14 between Croatia and Turkey?
- 0.5%, with Croatia ahead.
- How many years of comparable data are there for Croatia and Turkey?
- 6 years are reported by both, from 2000 to 2021.
- How do Croatia and Turkey rank globally for cause of death, by non-communicable diseases, ages 5-14?
- Croatia ranks 42nd and Turkey ranks 43rd of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 5-14 (% of total deaths ages 5-14). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths ages 5-14 due to non-communicable diseases divided by number of all deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.